HCPCS Code C1767: Generator, neurostimulator implantable, non-rechargeable

Key Takeaways

HCPCS Code C1767 describes a Generator, neurostimulator (implantable), non-rechargeable – a Level II HCPCS device code used in outpatient hospital and ASC settings.

C1767 is a Medicare pass-through device category code billed under the Outpatient Prospective Payment System (OPPS); pass-through status has defined expiration periods – verify current status before billing.

Documentation must include operative notes, device invoice, implant log, and medical necessity criteria; missing documentation is the leading cause of claim denials for this code.

Pabau’s claims management software helps outpatient billing teams capture required device documentation at the point of care, reducing C1767 claim errors before submission.

Hospital outpatient billing teams routinely flag implantable device codes as a denial risk – and C1767 is near the top of that list. Claims submitted without a device invoice, a complete operative note, or verified pass-through status are returned before they ever reach adjudication. According to CMS, HCPCS Level II device codes require specific supporting documentation that differs from standard procedure codes, and coders who treat C1767 like a routine supply code consistently encounter avoidable rejections.

HCPCS Code C1767 describes a generator, neurostimulator (implantable), non-rechargeable. This guide covers the official code description, Medicare OPPS coverage and pass-through status, 2026 fee schedule rates, step-by-step billing guidance, documentation requirements, applicable modifiers, and related C-series codes.

HCPCS Code C1767: definition and code attributes

HCPCS Code C1767 is a Level II HCPCS code maintained by the Centers for Medicare and Medicaid Services (CMS). It describes a single implantable, non-rechargeable neurostimulator generator. The code sits within the C-series device category, which CMS created specifically for items that qualify for temporary pass-through payment status under the Medicare Outpatient Prospective Payment System (OPPS).

The distinction between rechargeable and non-rechargeable is clinically and commercially meaningful. Non-rechargeable devices require surgical replacement when battery life ends, while rechargeable units can be charged transcutaneously. From a coding standpoint, billing a rechargeable device under C1767 constitutes a misuse of the code and may trigger a false-claims concern. Always confirm device specifications from the manufacturer’s documentation before assigning C1767.

The AHA Coding Clinic issued a description revision for C1767 to better reflect the full range of non-rechargeable implantable neurostimulator generators covered under the code. Coders relying on older reference materials may encounter the pre-revision wording; always verify the current official CMS description is in use. For teams managing EHR integration for billing workflows, having a system that surfaces the current code description at the point of documentation reduces this risk significantly.

Medicare coverage and OPPS payment for HCPCS Code C1767

C1767 is covered under Medicare through the Outpatient Prospective Payment System (OPPS). Under OPPS, the hospital outpatient department bundles most services into Ambulatory Payment Classifications (APCs), but devices that qualify for pass-through status receive a separate, additional payment on top of the APC.

Pass-through status exists to ensure hospitals are not financially disadvantaged when using newer, higher-cost devices that have not yet been incorporated into APC weights. CMS grants pass-through status for a defined transitional period, generally two to three years. Once that window closes, the device cost is folded into the relevant APC and no separate device payment is made.

Key OPPS payment facts for C1767:

• Payment is made to the Hospital Outpatient Department (HOPD) or ASC, not to individual practitioners.
• The pass-through payment is calculated as the difference between the device’s cost and the portion of the APC payment attributable to the device.
• Geographic Payment Cost Indices (GPCIs) do not directly adjust C-code pass-through rates the same way they adjust physician fee schedule amounts; OPPS uses wage-index adjustments instead.
• Pass-through status must be verified against the current CMS OPPS Addendum B before billing; claiming expired pass-through status is an audit risk.
• For ASC settings, coverage follows specific ASC payment rules, which may differ from HOPD rates; confirm with the applicable CMS ASC payment addendum.

Local Coverage Determinations (LCDs) issued by Medicare Administrative Contractors (MACs) govern which diagnoses support medical necessity for implantable neurostimulator generators. Coverage for C1767 may be restricted by the MAC’s LCD for neurostimulation. Never assume universal coverage without reviewing the applicable LCD for the patient’s MAC jurisdiction.

2026 fee schedule rates for HCPCS Code C1767

CMS publishes annual OPPS payment rates through Addendum B of the OPPS final rule. Because C1767 is a pass-through device code, its payment amount reflects the device acquisition cost rather than a fixed fee schedule rate in the traditional sense. Payment amounts are adjusted annually and vary based on submitted device cost data.

The table below summarises the key fee schedule variables billing teams need to track. Specific dollar amounts change each fiscal year and should always be confirmed against the current CMS OPPS Addendum B or the CMS Physician Fee Schedule lookup for cross-reference purposes.

For the most current dollar figures, consult the CMS HCPCS overview page or your MAC’s published fee schedule. Rates pulled from aggregator sites like PayerPrice reflect CMS source data but may lag by a billing cycle; always cross-reference against the primary CMS publication for audit-defensible documentation.

Stop chasing missing device documentation

Pabau's claims management software helps hospital billing teams capture required device invoices and operative notes at the point of care – so C1767 claims go out clean the first time.

Book a demo

Billing guidelines for HCPCS Code C1767

Billing C1767 incorrectly is one of the most common sources of implantable device claim rejections. Most errors stem from submitting the code in the wrong setting, omitting required modifiers, or failing to include the device invoice. The billing steps below apply to hospital outpatient department claims under Medicare OPPS. For claims management software that flags missing components before submission, teams report significantly fewer rework cycles.

1. Confirm the setting. C1767 is billable in the HOPD and ASC settings only. Inpatient hospital claims use DRG-based payment; C1767 does not apply in that context.
2. Verify the device type. Confirm the implanted device is non-rechargeable. Review the manufacturer’s product specification sheet and the operative note. Billing C1767 for a rechargeable device is incorrect; C1778 or another rechargeable-device code applies in that case.
3. Confirm pass-through status. Check the current CMS OPPS Addendum B to confirm C1767 retains active pass-through status for the date of service. Submitting after pass-through expiration results in denial of the separate device payment.
4. Report the device on the UB-04. Place C1767 on revenue code 0624 (implantable devices) or the appropriate device revenue code per your facility’s chargemaster. Include one unit per device implanted.
5. Attach required modifiers. Apply modifiers as dictated by LCD medical necessity criteria and claim-specific circumstances (see the modifiers section below).
6. Include the device invoice. Attach or document the acquisition cost of the device. Medicare pass-through payment is tied to actual cost; claims without supporting cost documentation face delay or denial.
7. Apply HIPAA-compliant transmission protocols. Submit via the 837I (institutional) electronic claim format. Review HIPAA-compliant billing practices for your facility to ensure EDI transmission meets current CMS requirements.

Documentation requirements for outpatient hospital C1767 claims

Documentation failures are the primary driver of C1767 claim denials. Medicare’s pass-through payment mechanism requires that the acquisition cost of the device be substantiated, which goes beyond what standard procedure code billing demands. Strong clinical documentation at point of care disciplines built into your department’s workflow prevent the downstream scramble during audits.

The following documentation elements are required or strongly recommended for every C1767 claim:

• Operative note: Must identify the specific device implanted, confirm it is non-rechargeable, document the implantation procedure, and be signed by the performing surgeon.
• Device invoice or acquisition cost record: Shows the actual cost paid by the facility for the specific device. This substantiates the pass-through payment amount.
• Implant log or device log: The facility’s implant log entry recording device lot number, serial number, manufacturer, and model is required for traceability and supports both the claim and Joint Commission requirements.
• Medical necessity documentation: The patient’s record must support the diagnosis that triggers the LCD criteria for implantable neurostimulation. Typically this includes trial stimulation results, failed conservative treatment documentation, and the diagnosing physician’s notes.
• Physician orders: Written orders authorising the device implantation procedure, signed prior to the procedure date of service.
• Patient consent: Signed informed consent specific to the implantable neurostimulator procedure and any manufacturer-specific device registration requirements.

Building these elements into your facility’s pre-procedure checklist ensures documentation is available at claim submission rather than reconstructed retroactively. Digital forms for clinical documentation that are completed before the patient leaves the department close the most common gap: missing consent and implant log entries. Robust patient compliance documentation also supports the medical necessity record when a MAC reviews the claim.

Common modifiers used with HCPCS Code C1767

Modifiers provide Medicare and other payers with additional claim context that affects payment determination. Applying the wrong modifier, or omitting a required one, is a frequent cause of denials and compliance flags. The table below covers the modifiers most commonly associated with C1767 claims. Behavioral health coding guidelines follow similar modifier logic for other specialty codes, illustrating how broadly these rules apply across HCPCS billing.

Critical compliance note: appending -KX without documented LCD criteria in the medical record constitutes improper billing and may be viewed as a false attestation during a post-payment audit. Review the applicable MAC’s LCD before applying this modifier on any C1767 claim.

Related and crosswalk HCPCS codes for neurostimulator generators

The C-series includes several neurostimulator-related codes that are commonly confused with C1767. Selecting the wrong code typically results in a claim denial that requires a costly corrected claim process. The comparison table below covers the most frequently encountered C-series codes in this clinical area. For broader context on procedure code families, teams billing neurology and therapy procedure codes will recognise the same device-category logic at work.

When billing a complete spinal cord stimulator implantation, teams typically report C1767 for the generator alongside C1778 for the lead. Billing only C1767 without the lead code, or billing the lead without the generator, will result in an incomplete claim that does not reflect the actual cost of the procedure. For teams managing device-heavy specialties, the same logic applies to reproductive medicine procedure codes where multi-component device billing is also standard practice.

Payer coverage policies beyond Medicare

Medicare OPPS governs the primary billing context for C1767, but commercial payers and Medicaid programs have independent coverage policies that vary significantly. This is a content gap most reference sites do not address, and it is where billing teams encounter the most unexpected denials.

Commercial payer coverage for implantable neurostimulator generators typically follows these patterns:

• Prior authorization is almost universally required. Most major commercial plans (including Blues plans, Aetna, Cigna, and UHC) require pre-authorization for implantable neurostimulation procedures. The C1767 device code is included in that authorization, not just the implantation CPT code.
• Medical necessity criteria differ from Medicare LCDs. Commercial plans apply their own coverage criteria, which may require longer documented failed conservative treatment periods or specific diagnosis requirements not found in the MAC’s LCD.
• Device-specific coverage policies may apply. Some payers maintain lists of approved device manufacturers or models. A non-rechargeable IPG from a manufacturer not on the approved list may be denied even when the procedure itself is covered.
• Medicaid coverage is state-dependent. State Medicaid programs vary in whether they cover implantable neurostimulation at all; some states follow Medicare LCD criteria, others apply more restrictive criteria, and some require carve-out authorization through a managed care organization.

Before scheduling an implantation, confirm the payer’s specific authorization requirements and obtain written authorization that explicitly covers the device (not just the surgical procedure). Keeping strong medical necessity documentation for specialty conditions on file is equally important for commercial payer audits, which are increasingly data-driven.

Your facility’s compliance management workflows should include a payer-specific coverage matrix for high-cost implantable devices to prevent authorization gaps.

Manufacturer reimbursement guides from Boston Scientific and Medtronic provide payer-specific coverage summaries for their neurostimulation product lines and are a practical secondary resource for commercial payer navigation, alongside the AAPC Codify HCPCS lookup for code-level payer policy checks.

Streamlining C1767 billing in your practice management system

Device codes like C1767 expose a structural weakness in many outpatient billing workflows: the documentation required to support the claim exists across multiple departments (surgical suite, materials management, medical records) and must be consolidated before the claim goes out. When those pieces live in separate systems, claims are submitted with gaps.

Pabau’s claims management software brings device documentation, clinical notes, and billing codes into a single workflow. Coders reviewing C1767 claims can see the operative note, the implant log entry, and the device invoice within the same patient record rather than hunting across systems.

For facilities also managing practice management software features across multiple departments, the consolidated approach removes the most common pre-submission gap.

Conclusion

C1767 claim denials almost always trace back to the same root causes: expired pass-through status that was not caught in the chargemaster, a missing device invoice, or a -KX modifier appended without a complete LCD documentation set. These are preventable errors.

Pabau’s digital forms for clinical documentation and integrated claims workflow help outpatient billing teams close those gaps before submission, keeping C1767 claims clean and audit-ready. To see how Pabau supports device-heavy outpatient billing, book a demo.

Continue your research

Need to manage billing compliance across your practice? HIPAA compliance for clinic software covers the documentation and system requirements billing teams need to meet federal standards.

Looking to reduce claim errors across all code types? Medical practice business plan outlines how to build structured billing workflows into your practice’s operational foundation.

Managing documentation for complex outpatient procedures? Pabau’s client record management keeps operative notes, device logs, and consent forms in one place for seamless claim support.

Frequently asked questions about HCPCS Code C1767